(Q81284330)
Statements
Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis (English)
Alan Menter
Kenneth Gordon
Wayne Carey
Tiffani Hamilton
Scott Glazer
Ivor Caro
Nicole Li